Moderna plans 400% increase in price of Covid vaccine
Public Citizen Access to Medicines Director Peter Maybarduk and Northwestern healthcare economist Craig Garthwaite joins CNBC’s Brian Sullivan and ‘Last Call’ to discuss the debate over Moderna’s decision to raise the price of its Covid vaccine.
UP NEXT
UP NEXT
-
'Crypto is not going away', says Digital Chamber's Perianne Boring on SEC lawsuit against Binance
CNBC
-
At the end of the day 'this is a war', says fmr. Amb. McFaul on Ukraine-U.S. Nord Stream report
CNBC
-
There will be a huge drop in spending once student loan payments resume, says Landry's CEO Fertitta
CNBC
-
'Yasir Al-Rumayyan is going to be the most powerful person' in golf, says Barstool's Sam Bozoian
CNBC
-
Lightning Round: If you have to buy Chinese stock buy Alibaba, says Jim Cramer
CNBC
-
Timothy Massad: crypto risk 'isn't just about the token' it's about the 'platform you're trading on'
CNBC
-
I wish someone would tell people messing in crypto it's possible to lose everything, says Jim Cramer
CNBC
-
Most crypto assets named in SEC brief look like 'scams', says Jim Cramer
CNBC
-
Magic Leap CEO: 'All boats are rising' in VR headset space after Apple introduces the Vision Pro
CNBC
-
Call of the Day: SVB MoffettNathanson upgrades AT&T to Market Perform
CNBC
-
Options Action: Puts outpacing calls for Coinbase
CNBC
-
Merck's challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
CNBC
-
Former SEC chair Jay Clayton breaks down new lawsuits against Binance and Coinbase
CNBC
-
CNBC Markets Now: June 6, 2023
CNBC
-
Companies aren't going to just 'walk away from China', says KraneShares' Brendan Ahern
CNBC
-
Post-Market Wrap: June 6, 2023
CNBC